Clinical Nephrology – Epidemiology – Clinical TrialsSevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients
Under an Elsevier user license
open archive
Keywords
randomized clinical trial
cardiovascular calcification
end-stage renal disease
mineral metabolism
hypercalcemia
Cited by (0)
- 1
The Treat to Goal Working Group members include (United States) G.M. Chertow and G. Caputo (San Francisco, CA); P. Raggi (New Orleans, LA); G. Schulman (Nashville, TN); A. Kuhlik, M. Derman and M. Clouse (Boston, MA); J.T. McCarthy and J. Breen (Rochester, MN); J. Silberzweig and J. Markisz (New York, NY); W. Goodman and J. Goldin (Los Angeles, CA); R. Toto and M. Boyce (Dallas, Texas); (Germany) J. Bommer (Heidelberg); H.H. Neumayer, R. Krause, G. Asmus and B. Hamm (Berlin); R. Brunkhors (Hannover); D.H.W. Grönemeyer (Bochum); W. Schulz (Bamberg); J. Braun (Nürnberg); M. Georgi (Mannheim); S. Achenbach and W. Moshage (Erlangen); and (Austria) H. Holzer and R. Rienmüller (Graz).
Copyright © 2002 International Society of Nephrology. Published by Elsevier Inc. All rights reserved.